251 related articles for article (PubMed ID: 4673250)
1. L-dopa in Parkinsonism. A possible mechanism of action.
Ng LK; Chase TN; Colburn RW; Kopin IJ
Neurology; 1972 Jul; 22(7):688-96. PubMed ID: 4673250
[No Abstract] [Full Text] [Related]
2. Drugs affecting monoamines in the basal ganglia.
Bartholini G; Pletscher A
Adv Biochem Psychopharmacol; 1972; 6():135-48. PubMed ID: 4560163
[No Abstract] [Full Text] [Related]
3. Enhancement by 6-hydroxydopamine of the effects of DOPA upon the motor activity of rats.
Schoenfeld RI; Uretsky NJ
J Pharmacol Exp Ther; 1973 Sep; 186(3):616-24. PubMed ID: 4728340
[No Abstract] [Full Text] [Related]
4. Degeneration of central and peripheral noradrenaline neurons produced by 6-hydroxy-DOPA.
Sachs C; Jonsson G
J Neurochem; 1972 Jun; 19(6):1561-75. PubMed ID: 5035304
[No Abstract] [Full Text] [Related]
5. Axoplasmic transport of dopamine in nigro-striatal neurons.
Fibiger HC; McGeer EG; Atmadja S
J Neurochem; 1973 Aug; 21(2):373-85. PubMed ID: 4125072
[No Abstract] [Full Text] [Related]
6. L-Dopa-induced release of cerebral monoamines.
Ng KY; Chase TN; Colburn RW; Kopin IJ
Science; 1970 Oct; 170(3953):76-7. PubMed ID: 5452893
[TBL] [Abstract][Full Text] [Related]
7. Effects of L-dopa on behavior and on brain amines in mice treated with 6-hydroxydopamine.
Barnes L; Cann F; Karczmar AG; Kindel G; Longo VG
Pharmacol Biochem Behav; 1973; 1(1):35-40. PubMed ID: 4775581
[No Abstract] [Full Text] [Related]
8. Striatonigral degeneration. Response to levodopa therapy with pathological and neurochemical correlation.
Sharpe JA; Rewcastle NB; Lloyd KG; Hornykiewicz O; Hill M; Tasker RR
J Neurol Sci; 1973 Jul; 19(3):275-86. PubMed ID: 4716845
[No Abstract] [Full Text] [Related]
9. [The role of dopamine in the physiology and pathology of the basal ganglia].
Arushanian EB
Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(4):595-603. PubMed ID: 4341763
[No Abstract] [Full Text] [Related]
10. Effect of long-term L-dopa administration on brain biogenic amines and behavior in the rat.
Narotzky R; Griffith D; Stahl S; Bondareff W; Zeller EA
Exp Neurol; 1973 Feb; 38(2):218-30. PubMed ID: 4690179
[No Abstract] [Full Text] [Related]
11. Effects of L-dopa on accumulation and efflux of monoamines in particles of rat brain homogenates.
Ng LK; Colburn RW; Kopin IJ
J Pharmacol Exp Ther; 1972 Nov; 183(2):316-25. PubMed ID: 5083548
[No Abstract] [Full Text] [Related]
12. Release of ( 3 H)dopamine by L-5-hydroxytryptophan.
Ng LK; Chase TN; Colburn RW; Kopin IJ
Brain Res; 1972 Oct; 45(2):499-505. PubMed ID: 4539008
[No Abstract] [Full Text] [Related]
13. Turning behavior of mice with unilateral 6-hydroxydopamine lesions in the striatum: effects of apomorphine, L-DOPA, amanthadine, amphetamine and other psychomotor stimulants.
Von Voigtlander PF; Moore KE
Neuropharmacology; 1973 May; 12(5):451-62. PubMed ID: 4145343
[No Abstract] [Full Text] [Related]
14. Effects of L-dopa on efflux of cerebral monoamines from synaptosomes.
Ng KY; Colburn RW; Kopin IJ
Nature; 1971 Apr; 230(5292):331-2. PubMed ID: 5549411
[No Abstract] [Full Text] [Related]
15. Dopamine: stimulation-induced release from central neurons.
Ng KY; Chase TN; Colburn RW; Kopin IJ
Science; 1971 Apr; 172(3982):487-9. PubMed ID: 5550505
[TBL] [Abstract][Full Text] [Related]
16. Drug-induced changes in brain dopamine and their relation to parkinsonism.
Vogt M
Sci Basis Med Annu Rev; 1970; ():276-91. PubMed ID: 4319923
[No Abstract] [Full Text] [Related]
17. Acute effects of morphine on dopamine synthesis and release and tyrosine metabolism in the rat striatum.
Gauchy C; Agid Y; Glowinski J; Cheramy A
Eur J Pharmacol; 1973 Jun; 22(3):311-9. PubMed ID: 4354579
[No Abstract] [Full Text] [Related]
18. Effect of L-DOPA on S-adenosylmethionine levels and norepinephrine metabolism in rat brain.
Wurtman RJ
Adv Biochem Psychopharmacol; 1972; 6():241-6. PubMed ID: 5055596
[No Abstract] [Full Text] [Related]
19. Biochemical and pharmacological aspects of Parkinsonism.
Carlsson A
Acta Neurol Scand Suppl; 1972; 51():11-42. PubMed ID: 4351191
[No Abstract] [Full Text] [Related]
20. Parkinson's disease: from brain homogenate to treatment.
Hornykiewicz O
Fed Proc; 1973 Feb; 32(2):183-90. PubMed ID: 4143953
[No Abstract] [Full Text] [Related]
[Next] [New Search]
